1910 Genetics
AI Drug Discovery
5 open rolesAI Drug DiscoveryBoston, United States42 employees$30M raisedEst. 2018
Y Combinator
M12
Playground Global
Sam Altman
FoundersX Ventures
Scientia Ventures
About 1910 Genetics
- 1910 (formerly 1910 Genetics) is an AI-native biotech company integrating AI, computation, and biological automation to accelerate the design of small molecule and protein therapeutics.
- Their multimodal AI platform, ITO™, helps biopharma companies transform drug discovery by making undruggable targets a thing of the past.
1910 Genetics is listed on Rocketlist with 5 active roles. The company is categorized as AI Drug Discovery in BioTech. 1910 Genetics is at Series A stage, with a B2B business model, headquartered in Boston, United States. 1910 Genetics was founded in 2018 and has 42 employees. 1910 Genetics has raised $30M. Active roles are refreshed daily from public hiring sources.